AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28833428 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback reports containing information in combination with response certitude
Number of subjects: 0
Study 28833428 — intervention group
Group type: COMPARATOR
Intervention: General feedback (not specified)
Number of subjects: 0
Study 25625938 — intervention group
Group type: EXPERIMENTAL
Intervention: D3P (docetaxel: 75 mg/m2, intravenous infusion, every three weeks; Prednisone 10mg orally daily)
Number of subjects: 228
Study 25625938 — intervention group
Group type: COMPARATOR
Intervention: M3P (mitoxantrone: 12 mg/m2, intravenous infusion, every three weeks; Prednisone 10mg orally daily)
Number of subjects: 228
Study 23553700 — intervention group
Group type: EXPERIMENTAL
Intervention: END anti-stigma programme (intervention group)
Number of subjects: 1452
Study 23553700 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1452
Study 21208227 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal sensed AV delay of 129 ± 19 ms during Sinus rhythm
Number of subjects: 33
Study 21208227 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal paced AV delay of 175 ± 24 ms during atrial pacing
Number of subjects: 33
Study 21208227 — intervention group
Group type: EXPERIMENTAL
Intervention: P-wave duration (PWd) during Sinus rhythm
Number of subjects: 33
Study 21208227 — intervention group
Group type: EXPERIMENTAL
Intervention: RA-RV interval during Sinus rhythm
Number of subjects: 33
Study 18806198 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative research methods applied to improve recruitment rates in RCTs
Number of subjects: 0
Study 18806198 — intervention group
Group type: COMPARATOR
Intervention: ProtecT study's complex intervention
Number of subjects: 0
Study 16937176 — intervention group
Group type: EXPERIMENTAL
Intervention: Water environment (32 degrees C)
Number of subjects: 10
Study 16937176 — intervention group
Group type: COMPARATOR
Intervention: Air environment
Number of subjects: 10
Study 12725963 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated data extraction system for ECG
Number of subjects: 0
Study 10849573 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese children (BMI > 95th percentile)
Number of subjects: 124
Study 10849573 — intervention group
Group type: COMPARATOR
Intervention: Non-obese children (10th percentile < BMI > 90th percentile)
Number of subjects: 124
Study 9014663 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasonography with adapted urethral probe
Number of subjects: 200
Study 9014663 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasonography with specialized laparoscopic probe
Number of subjects: 200
Study 9014663 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative cholangiography
Number of subjects: 200
Study 9014663 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasonography
Number of subjects: 200
Study 9014663 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasonography with specialized probe
Number of subjects: 200
Study 1396621 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline (250 mg for children, 500 mg for adults)
Number of subjects: 120
Study 1396621 — intervention group
Group type: COMPARATOR
Intervention: Procaine penicillin (200,000 units for children, 600,000 IU for adults)
Number of subjects: 120
Study 3530366 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumarin treatment
Number of subjects: 71
Study 3530366 — intervention group
Group type: COMPARATOR
Intervention: No anticoagulant treatment (Control)
Number of subjects: 71
Study 3530366 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumarin treatment (in limb salvage surgery)
Number of subjects: 71
Study 3530366 — intervention group
Group type: COMPARATOR
Intervention: No anticoagulant treatment (Control, in limb salvage surgery)
Number of subjects: 71
Study 3530366 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall results for limb salvage surgery
Number of subjects: 71
Study 3530366 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall results for stages II and II-III
Number of subjects: 71
Study 3530366 — intervention group
Group type: EXPERIMENTAL
Intervention: Site of distal anastomosis (above knee)
Number of subjects: 71
Study 3530366 — intervention group
Group type: EXPERIMENTAL
Intervention: Site of distal anastomosis (below knee)
Number of subjects: 71
Study 31750598 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse case management (NCM)
Number of subjects: 68
Study 31750598 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 68
Study 28718987 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 10
Study 28718987 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 10
Study 28718987 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 10
Study 27161812 — intervention group
Group type: EXPERIMENTAL
Intervention: Inquiry-based peer-assisted learning project (bioinformatics module)
Number of subjects: 0
Study 27161812 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and post-module quizzes
Number of subjects: 0
Study 27161812 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative assessment via post-module surveys
Number of subjects: 0
Study 25009197 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol general anaesthesia with paravertebral analgesia (PPA)
Number of subjects: 20
Study 25009197 — intervention group
Group type: COMPARATOR
Intervention: Standard sevoflurane general anaesthesia with opioid analgesia (SGA)
Number of subjects: 20
Study 24047007 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-septal suture (Group A)
Number of subjects: 44
Study 24047007 — intervention group
Group type: COMPARATOR
Intervention: Intranasal pack (Group B)
Number of subjects: 44
Study 24047007 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study 20526911 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician estimates of calcium intake
Number of subjects: 97
Study 20526911 — intervention group
Group type: COMPARATOR
Intervention: Short Calcium Questionnaire (SCQ)
Number of subjects: 97
Study 18545201 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental carbohydrate (CHO) ingestion (0.3g.kgCHO.bodymass)
Number of subjects: 8
Study 18545201 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC) of equal volume
Number of subjects: 8
Study 15941890 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (50-800 microg/d)
Number of subjects: 308
Study 15941890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study 15941890 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 308
Study 12697487 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole treatment group
Number of subjects: 114
Study 10432616 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol consumption (approximately 0.3 g/kg) as beer, white wine, or vodka mixed with orange juice
Number of subjects: 10
Study 10432616 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal compression belt applied to provoke gastroesophageal reflux
Number of subjects: 10
Study 8520505 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDC) and total body irradiation (TBI) followed with autologous blood stem cell transplantation (ABSCT)
Number of subjects: 167
Study 8520505 — intervention group
Group type: COMPARATOR
Intervention: Conventional vincristine, melphalan, cyclophosphamide and prednisone (VMCP) regimen
Number of subjects: 167
Study 8520505 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival for all patients
Number of subjects: 167
Study 1722692 — intervention group
Group type: EXPERIMENTAL
Intervention: Mu‐cron tablets (phenylpropanolamine 50 mg)
Number of subjects: 16
Study 1722692 — intervention group
Group type: EXPERIMENTAL
Intervention: Boots Cold Relief tablets (phenylephrine 10 mg and caffeine 60 mg)
Number of subjects: 16
Study 1722692 — intervention group
Group type: COMPARATOR
Intervention: Boots Pain Relief tablets (caffeine 60 mg)
Number of subjects: 16
Study 6460717 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine at 75 mg/day
Number of subjects: 20
Study 6460717 — intervention group
Group type: EXPERIMENTAL
Intervention: Zimelidine at 100 mg/day
Number of subjects: 20
Study 6460717 — intervention group
Group type: EXPERIMENTAL
Intervention: Zimelidine at 200 mg/day
Number of subjects: 20
Study 6460717 — intervention group
Group type: COMPARATOR
Intervention: Imipramine at 25 mg three times daily
Number of subjects: 20
Study 31482197 — intervention group
Group type: EXPERIMENTAL
Intervention: tRNS (1 mA for 10 min)
Number of subjects: 30
Study 31482197 — intervention group
Group type: EXPERIMENTAL
Intervention: 140 Hz tACS (1 mA for 10 min)
Number of subjects: 30
Study 31482197 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (10 min)
Number of subjects: 30
Study 28994033 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulator (HFS)
Number of subjects: 36
Study 28994033 — intervention group
Group type: COMPARATOR
Intervention: Low-fidelity simulator (LFS)
Number of subjects: 36
Study 28994033 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall improvement
Number of subjects: 36
Study 28994033 — intervention group
Group type: EXPERIMENTAL
Intervention: Total improvement
Number of subjects: 36
Study 28994033 — intervention group
Group type: EXPERIMENTAL
Intervention: Postgraduate year
Number of subjects: 36
Study 28994033 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialty
Number of subjects: 36
Study 25882474 — intervention group
Group type: EXPERIMENTAL
Intervention: Head vibration
Number of subjects: 18
Study 25882474 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental distraction
Number of subjects: 18
Study 25882474 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined effect of head vibration and mental distraction
Number of subjects: 18
Study 24314888 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 or 120 mg/day
Number of subjects: 0
Study 24314888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22545079 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory and clinical monitoring (LCM)
Number of subjects: 3316
Study 22545079 — intervention group
Group type: COMPARATOR
Intervention: Clinically-driven monitoring (CDM)
Number of subjects: 3316
Study 22545079 — intervention group
Group type: COMPARATOR
Intervention: Routine toxicity monitoring
Number of subjects: 3316
Study 22545079 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine 12-weekly CD4 monitoring from year 2 on ART
Number of subjects: 3316
Study 20069805 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoporosis educational intervention
Number of subjects: 105
Study 20069805 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 105
Study 17440203 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion expressions resembling babies
Number of subjects: 0
Study 17440203 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion expressions
Number of subjects: 0
Study 17440203 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective indices of babyfaceness
Number of subjects: 0
Study 17440203 — intervention group
Group type: EXPERIMENTAL
Intervention: Attractiveness
Number of subjects: 0
Study 17440203 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy expressions
Number of subjects: 0
Study 15244106 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 18
Study 15244106 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaerobic exercise
Number of subjects: 18
Study 15244106 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 18
Study 12397189 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal abdominal hysterectomy
Number of subjects: 279
Study 12397189 — intervention group
Group type: COMPARATOR
Intervention: Total abdominal hysterectomy
Number of subjects: 279
Study 12397189 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 279
Study 9667165 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitizing agents (specific agents not detailed)
Number of subjects: 77
Study 9667165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 7855203 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentagastrin (0.1, 0.3, and 0.6 microgram/kg)
Number of subjects: 30
Study 7855203 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 30
Study 2671289 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin (CBDCA) plus Methotrexate (MTX) - CBDCA administered IV monthly at doses of 400 mg/m2, MTX given IV weekly at doses of 40 mg/m2.
Number of subjects: 40
Study 2671289 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) alone - administered IV weekly at doses of 40 mg/m2.
Number of subjects: 40
Study 335903 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride (intravenous administration)
Number of subjects: 12
Study 335903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31984514 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol beverage
Number of subjects: 165
Study 31984514 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo beverage
Number of subjects: 165
Study 31984514 — intervention group
Group type: EXPERIMENTAL
Intervention: Told-no-alcohol beverage
Number of subjects: 165
Study 31984514 — intervention group
Group type: COMPARATOR
Intervention: Control (no alcohol)
Number of subjects: 165
Study 31184783 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intervention
Number of subjects: 0
Study 31184783 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 0
Study 28917376 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayurvedic nutritional counseling
Number of subjects: 34
Study 28917376 — intervention group
Group type: COMPARATOR
Intervention: Conventional nutritional counseling
Number of subjects: 34
Study 25694417 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib plus capecitabine (LAP+CAP) 1250mg/day and 2000mg/m² on days 1-14 of a 21-day cycle
Number of subjects: 37
Study 25694417 — intervention group
Group type: COMPARATOR
Intervention: Lapatinib (LAP) 1500mg monotherapy on days 1-21
Number of subjects: 37
Study 25694417 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib plus capecitabine (LAP+CAP)
Number of subjects: 37
Study 25694417 — intervention group
Group type: COMPARATOR
Intervention: Lapatinib (LAP)
Number of subjects: 37
Study 25694417 — intervention group
Group type: COMPARATOR
Intervention: Lapatinib (LAP) and Lapatinib plus capecitabine (LAP+CAP)
Number of subjects: 37
Study 23107074 — intervention group
Group type: EXPERIMENTAL
Intervention: Thulium laser resection of the prostate (TMLRP)
Number of subjects: 100
Study 23107074 — intervention group
Group type: COMPARATOR
Intervention: Bipolar transurethral plasmakinetic prostatectomy (TUPKP)
Number of subjects: 100
Study 23107074 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of TMLRP and TUPKP
Number of subjects: 100
Study 21622028 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise
Number of subjects: 301
Study 21622028 — intervention group
Group type: COMPARATOR
Intervention: Chiropractic spinal manipulation
Number of subjects: 301
Study 21622028 — intervention group
Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 301
Study 20128352 — intervention group
Group type: EXPERIMENTAL
Intervention: Group MAP (antimalarial, retinol supplement, and anti-parasitic drug)
Number of subjects: 93
Study 20128352 — intervention group
Group type: EXPERIMENTAL
Intervention: Group MA (antimalarial and retinol supplement)
Number of subjects: 93
Study 20128352 — intervention group
Group type: EXPERIMENTAL
Intervention: Group MP (antimalarial and anti-parasitic drug)
Number of subjects: 93
Study 20128352 — intervention group
Group type: COMPARATOR
Intervention: Group M (treatment only with antimalarials)
Number of subjects: 93
Study 16956456 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA-PEG-3 cocamide sulfate
Number of subjects: 22
Study 16956456 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPB
Number of subjects: 22
Study 12723459 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dichloroacetate (DCA) 50 mg/kg
Number of subjects: 124
Study 10757193 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone 20 mg/day
Number of subjects: 20
Study 10757193 — intervention group
Group type: COMPARATOR
Intervention: Placebo 20 mg/day
Number of subjects: 20
Study 9032632 — intervention group
Group type: EXPERIMENTAL
Intervention: Air Flushing Clean System (AFCS) without dental vacuum suction
Number of subjects: 0
Study 9032632 — intervention group
Group type: EXPERIMENTAL
Intervention: Air Flushing Clean System (AFCS) with dental vacuum suction
Number of subjects: 0
Study 9032632 — intervention group
Group type: COMPARATOR
Intervention: Conventional handpiece
Number of subjects: 0
Study 8486815 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (8 micrograms/kg)
Number of subjects: 8
Study 8486815 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (1.0 g/kg)
Number of subjects: 8
Study 3087488 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg twice daily)
Number of subjects: 301
Study 3087488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 29425372 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial sleep deprivation (PSD) for five nights with maximum 4 hours of sleep per night.
Number of subjects: 13
Study 29425372 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged period of PSD for eight nights with 4 hours of sleep per night.
Number of subjects: 13
Study 29425372 — intervention group
Group type: COMPARATOR
Intervention: Baseline sleep period with five nights of 8 hours spent in bed.
Number of subjects: 13
Study 27462009 — intervention group
Group type: EXPERIMENTAL
Intervention: SMC021 (0.8 mg/d)
Number of subjects: 4665
Study 27462009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4665
Study 27462009 — intervention group
Group type: EXPERIMENTAL
Intervention: SMC021
Number of subjects: 4665
Study 25354769 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanochemical endovenous ablation (MOCA™)
Number of subjects: 160
Study 25354769 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 160
Study 22677763 — intervention group
Group type: EXPERIMENTAL
Intervention: Cereton (4 ml, 1000 mg intravenously for 10 days) in combination with traditional treatment
Number of subjects: 95
Study 22677763 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment only
Number of subjects: 95
Study 20453679 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH), 0.075 mg x kg(‐1) x day(‐1)
Number of subjects: 20
Study 20453679 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH)
Number of subjects: 20
Study 20453679 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids (CTX) alone
Number of subjects: 20
Study 17506156 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine + 6 mg mecamylamine
Number of subjects: 540
Study 17506156 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine + 3 mg mecamylamine
Number of subjects: 540
Study 17506156 — intervention group
Group type: COMPARATOR
Intervention: Nicotine only
Number of subjects: 540
Study 16388991 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized consent designs (incomplete-double-consent)
Number of subjects: 50
Study 16388991 — intervention group
Group type: COMPARATOR
Intervention: Randomized consent designs (single-consent)
Number of subjects: 50
Study 16388991 — intervention group
Group type: COMPARATOR
Intervention: Randomized consent designs (complete-double-consent)
Number of subjects: 50
Study 13129459 — intervention group
Group type: EXPERIMENTAL
Intervention: Fe alone
Number of subjects: 0
Study 13129459 — intervention group
Group type: EXPERIMENTAL
Intervention: Fe with other haematinics
Number of subjects: 0
Study 13129459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 13129459 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including placebo)
Number of subjects: 0
Study 13129459 — intervention group
Group type: EXPERIMENTAL
Intervention: Fe alone and Fe with other haematinics
Number of subjects: 0
Study 10823019 — intervention group
Group type: EXPERIMENTAL
Intervention: Written intervention (informing physicians about their own average and the group average)
Number of subjects: 11
Study 10823019 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 11
Study 9255000 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratumoural chlorpromazine (CPZ) with hypofractionated external radiation
Number of subjects: 43
Study 9255000 — intervention group
Group type: COMPARATOR
Intervention: Radiation alone (Control)
Number of subjects: 43
Study 1522842 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement every three days by insertion at a new site (group 1)
Number of subjects: 160
Study 1522842 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement every three days by exchange over a guide wire (group 2)
Number of subjects: 160
Study 1522842 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement when clinically indicated by insertion at a new site (group 3)
Number of subjects: 160
Study 1522842 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement when clinically indicated by exchange over a guide wire (group 4)
Number of subjects: 160
Study 1522842 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide-wire-assisted exchange
Number of subjects: 160
Study 1522842 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion at new sites
Number of subjects: 160
Study 1522842 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 160
Study 6340153 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon (1 mg I.V.)
Number of subjects: 185
Study 6340153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 31283355 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality-of-life group counseling (7 sessions every other day)
Number of subjects: 80
Study 30121128 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic spinal manipulation (TSM)
Number of subjects: 36
Study 30121128 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 36